Blade, Thanks. Also, looks like KURA has been doing well. Any thoughts on them? TIA.
Btw, I recently set up a board to follow the emerging 'Psychedelic Medicine' sector (link below). Back in 2019 I followed the saga of Spravato / Esketamine (the mirror image isomer of Ketamine), which received FDA approval for treatment resistant depression. It's become obvious that these substances are to be made legal (for better or worse), so the search by investors for early stage companies is on. An ETF just came out covering the sector (Horizons Psychedelic Stock Index ETF), but so far is only available in Canada -
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.